At a glance
ClinicalIndex Comparison RecordN/ACompleted· 56 enrolled
Drug / intervention
AmProt (amaranth protein isolate)dietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Dietary Supplementation With Amaranth Protein Isolate Modu-lates the Gut Microbiota in Children With Overweight and Obe-sity: A Nonrandomized Trial
Instituto Potosino De Investigacion Cientifica Y Tecnologica AC·interventional·Posted May 13, 2026·Updated May 13, 2026
In Brief
A clinical study evaluating AmProt (amaranth protein isolate) for Overweight and Obesity. Completed, enrolled 56 participants across 1 site.
Detailed Summary
The state of San Luis Potosí comprises several municipalities with diverse environmental conditions, ranging from semi-tropical to very arid zones. Arid zones have a high rate of childhood with obesity. This study aimed to investigate the effects of dietary supplementation with high-quality protein on the modulation of the gut microbiota.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOverweight and Obesity
CountriesMexico
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartMar 2018
Primary CompletionMar 2018
Study CompletionJun 2018
First PostedMay 2026
TodayJul 2026
First PostedMay 13, 2026
Enrollment StartMar 10, 2018
Primary CompletionMar 30, 2018
Study CompletionJun 30, 2018
TodayJul 2, 2026
Enrollment to primary: 20 daysPosted 2 months ago
Interventions
AmProt (amaranth protein isolate)dietary
Groups of children taken 2 g of amaranth protein isolate daily for 90 days